We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund

109 hedge funds and large institutions have $281M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $900K

1.16% more ownership

Funds ownership: 33.81%34.98% (+1.2%)

0% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 31

4% less capital invested

Capital invested by funds: $292M → $281M (-$10.4M)

4% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 28

2% less funds holding

Funds holding: 111109 (-2)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
109
Holders Change
-2
Holders Change %
-1.8%
% of All Funds
2.73%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
27
Increased
31
Reduced
31
Closed
28
Calls
$1.54M
Puts
$900K
Net Calls
+$645K
Net Calls Change
-$728K

FBT Hedge Fund Activity: Q4 2016 in Review

109 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2016, worth a combined $281M — down 3.6% from $292M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of FBT and 27 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 31 added.

The largest buyer was Morgan Stanley, adding an estimated $25.1M. The largest seller was Bank of America, cutting an estimated $3.05M.

  • 109 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2016, down from 111 in Q3 2016.
  • Funds reported $281M of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2016, down 3.6% quarter-over-quarter.
  • 27 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2016 and 28 closed out, a net change of -1 holder.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2016 was Morgan Stanley, an estimated $25.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2016 was Bank of America, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2016.